ClinicalTrials.Veeva

Menu

Sclerotherapy and Bone Marrow Injection In Aneurysmal Bone Cyst

A

Al-Azhar University

Status

Active, not recruiting

Conditions

Orthopedic Disorder

Treatments

Procedure: Sclerotherapy With Adjuvant Bone Marrow Injection In Management of Aneurysmal Bone Cyst

Study type

Observational

Funder types

Other

Identifiers

NCT05696834
SABMIMABC

Details and patient eligibility

About

Aneurysmal bone cysts (ABCs) are benign, locally destructive growing bone tumors, which were first described in 1942 by Jaffé and Lichtenstein (1). They are most often diagnosed in childhood and early adulthood. The literature reports that ABCs comprise 1-6% of all primary benign bone tumors (2). Most cases of ABCs (75-90%) are reported for patients younger than 20 years, with a slightly higher incidence for females (3). Most common localizations are the pelvis, the metaphysis of long bones and the spine, but ABCs can also affect any other localization(2). ABCs that are associated with a preexisting osseous lesion are defined as secondary ABCs. They represent approximately 30% of all ABCs (2). Secondary ABCs can occur, e.g., in cases of a giant cell tumor, chondroblastoma or telangiectatic osteosarcoma

Full description

The clinical symptoms of an ABC are usually accidently discovered or may consist of pain and swelling in the affected region and pathological fractures ( complete and incomplete ) can be observed occasionally. In conventional radiography a relatively well-defined osteolytic, expansile lesion with possible blowout of the periosteum and a soap-bubble appearance can be found (4). MRI scanning shows cystic formations with typical fluid-fluid levels due to blood sedimentation (7). Because of the possible rapid growth with local destruction, the literature describes cases of ABCs that mimic malignant bone tumors

Enrollment

20 patients

Sex

All

Ages

1+ year old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • All Patients above age of 1 year.
  • The affected area was all bones except skull, ribs, and other non-orthopedic specialties.
  • Primary or recurrent ABC
  • Incomplete Fractured affected bones as greenstick fracture.
  • Healed Pathological fracture without any surgical intervention

Exclusion criteria

  • ABC. In skull, ribs, and other non-orthopedic specialties.
  • Age less than 1 year
  • Suspected malignancy or other bone cysts
  • Complete fractured bones and healed pathological fracture with surgical intervention.

Trial design

20 participants in 1 patient group

sclerotherapy and bone marrow
Description:
Sclerotherapy With Adjuvant Bone Marrow Injection In Management of Aneurysmal Bone Cyst
Treatment:
Procedure: Sclerotherapy With Adjuvant Bone Marrow Injection In Management of Aneurysmal Bone Cyst

Trial contacts and locations

1

Loading...

Central trial contact

Ahmed Khashaba, MD; Ehab Elshal, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems